Korea to promote biosimilar industry

Published: 2011-12-19 06:58:00

Updated: 2011-12-19 06:58:00

The government recently unveiled its plan to nurture the biosimilar industry as one of its new growth engines, aiming to take a bigger share of the global market.

Biosimilars are officially approved subsequent versions of innovative biopharmaceutical products manufactured by different producer...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK